Weekly Drug News : January 23, 2019
Subscribe to Our Site to get updates direct to your email and Whats APP.

Weekly Drug News : January 23, 2019

With a U.S. government shutdown now extending into a second month, the FDA still manages to approve a third biosimilar for Herceptin known as Ontruzant. Plus, more recall updates are posted for the large class of blood pressure meds known as ARBs. Published studies look at other issues: aspirin use in healthy seniors, a new class of type 2 diabetes drug, and how treatment centers are addressing the ongoing opioid epidemic. 

#FDA #WeeklyUpdate #diabetes #opioid

© 2019 PHAF  || All rights reserved

  • Facebook Social Icon
  • Twitter Social Icon
  • Google+ Social Icon
  • YouTube Social  Icon
  • Instagram Social Icon

Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a healthcare professional.